MacroGenics

pulls plug pulling plug
Biotech

MacroGenics pulls plug on ADC after seeing phase 2 survival data

MacroGenics has made the call to abandon work on one of its more advanced antibody-drug conjugates after taking a look at the latest phase 2 data.
James Waldron Mar 21, 2025 7:15am
pause hold stop delay

MacroGenics pauses work on ADC pending mature survival data

Nov 6, 2024 4:44am
Paraglider over French coast

Biogen boosts C-suite with BMS vet—Chutes & Ladders

Nov 1, 2024 8:30am
sales decline revenue decline sales revenue stock stock market

MacroGenics' stock crashes after 5 deaths in ADC trial

May 10, 2024 6:00am
visual rendering of an antibody drug conjugate

AbbVie drops MacroGenics-partnered ADC in light of early data

Mar 8, 2024 8:20am
cash

Synaffix, MacroGenics crack open ADC pact, tack on $2.2B to deal

Mar 14, 2023 10:30am